New insider Vora Adesh Anil claimed ownership of 325,279 shares (SEC Form 3)
$SRXH
Beverages (Production/Distribution)
Consumer Staples
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/24/2025 |
3. Issuer Name and Ticker or Trading Symbol
SRx Health Solutions, Inc. [ SRXH ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 325,279 | I | Daughter who lives in the reporting person's household. |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 2,659,629 | $0.00 | D | |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 9,059,872 | $0.00 | I | NIAM PHARMACEUTICALS INC(2) |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 1,753,050 | $0.00 | I | ADESH VORA PHARMACY(2) |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 1,085,983 | $0.00 | I | TDDA THERAPEUTICS INC(2) |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 971,376 | $0.00 | I | VORA 2018 FAMILY TRUST(3) |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 954,341 | $0.00 | I | TRICARE CONSULTING INC(2) |
| Exchangeable Shares(1) | 04/24/2025 | 04/24/2027 | Common Stock | 173,644 | $0.00 | I | LIFE BEAUTIFUL DESIGNS INC(2) |
| Explanation of Responses: |
| 1. Exchangeable Shares of the Capital Stock of 1000994476 Ontario Inc., a corporation organized under the laws of Ontario, Canada and an indirect wholly owned subsidiary of the issuer ("Exchangeable Shares"). The Exchangeable shares were issued in connection with the business combination between the issuer and SRx Health Solutions, Inc., a corporation organized under the laws of Ontario, Canada, which was consummated on April 24, 2025. The Exchangeable Shares are exchangeable into shares of the issuer's Common Stock on a one-for-one basis for a period of up to two years from the date of issuance. |
| 2. The reporting person is an officer, director, and/or has a financial interest in the beneficial owner. |
| 3. The reporting person is the grantor, trustee, and/or beneficiary with respect to the beneficial owner. |
| /s/ Adesh Vora | 05/05/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||